equin
arter
viru
eav
small
envelop
positivestrand
rna
viru
famili
infect
hors
donkey
major
eav
infect
asymptomat
acut
infect
anim
may
develop
wide
rang
clinic
sign
includ
pyrexia
limb
ventral
edema
depress
rhiniti
conjunct
viru
may
caus
abort
caus
mortal
neonat
natur
eav
infect
hors
develop
solid
longterm
immun
diseas
mare
geld
elimin
viru
within
day
acut
infect
stallion
becom
persist
infect
persist
infect
anim
maintain
eav
within
reproduct
tract
shed
viru
continu
semen
transmit
viru
vener
mare
infect
vener
may
clinic
sign
shed
larg
amount
viru
nasopharyng
secret
urin
may
result
later
spread
infect
aerosol
rout
consequ
vener
acquir
infect
minim
known
effect
concept
rate
mare
infect
late
stage
gestat
may
abort
identif
carrier
stallion
crucial
control
dissemin
eav
stallion
identifi
serolog
screen
use
viru
neutral
vn
test
posit
titer
stallion
test
persist
infect
viru
isol
spermrich
fraction
ejacul
test
mate
shed
stallion
use
breed
bred
mare
seroposit
natur
infect
vaccin
mare
subsequ
isol
seroneg
hors
three
week
r
natur
artifici
insemin
live
attenu
arvac
formalininactiv
artervac
vaccin
avail
vaccin
induc
virusneutr
antibodi
presenc
correl
protect
diseas
abort
develop
persist
infect
serolog
investig
indic
eav
worldwid
distribut
preval
increas
consequ
increas
number
equin
viral
arter
eva
outbreak
report
trend
like
continu
unless
action
taken
slow
halt
transmiss
agent
semen
q
al
glaser
et
al
equin
viral
arter
diseas
recogn
hors
sinc
later
part
centuri
refer
epizoot
cellul
pinkey
equin
influenza
earli
veterinari
literatur
equin
arter
viru
strain
bucyru
owe
name
town
ohio
first
isol
abort
storm
outbreak
eva
transmit
respiratori
rout
howev
outbreak
kentucki
carrier
state
stallion
identifi
third
stallion
seroconvert
outbreak
found
persist
infect
research
demonstr
persist
infect
stallion
shed
viru
continu
semen
vener
infect
occur
mare
bred
stallion
find
first
direct
confirm
assumpt
made
earli
infecti
agent
present
semin
fluid
certain
stallion
transmit
vener
mare
mare
bred
shed
stallion
dissemin
viru
acut
stage
aerosol
transmiss
past
diseas
outbreak
identifi
infrequ
howev
increas
intern
travel
hors
competit
breed
shipment
semen
use
artifici
insemin
risk
viru
transmiss
increas
number
confirm
outbreak
risen
purpos
articl
review
recent
research
eav
provid
inform
strategi
clinic
diagnosi
viru
detect
diseas
prevent
control
equin
arter
viru
small
envelop
singlestrand
positivesens
rna
viru
virion
diamet
mn
consist
isometr
core
mn
surround
envelop
contain
small
surfac
project
eav
origin
classifi
nonarthropodborn
member
togavirida
basi
virion
morpholog
size
find
strike
similar
corona
virus
toro
virus
genom
organ
replic
strategi
recent
result
classif
eav
prototyp
member
new
famili
arterivirida
lo
within
propos
order
nidoviral
nest
set
virus
member
new
famili
includ
porcin
respiratori
reproduct
syndrom
viru
prrsv
simian
hemorrhag
fever
viru
shfv
murin
lactat
dehydrogenaseelev
viru
ldv
eav
genom
contain
open
read
frame
orf
figur
termin
genom
contain
larg
orf
orf
lalb
encod
protein
involv
viral
replic
genom
contain
small
orf
number
least
encod
structur
protein
nucleocapsid
protein
n
encod
orf
orf
encod
viral
membran
protein
gs
gl
respect
figur
function
protein
encod
orf
current
unknown
gl
n
predomin
protein
virion
compris
total
virion
protein
content
one
serotyp
eav
recogn
use
convalesc
equin
sera
cross
neutral
complement
fixat
cf
test
differ
exist
pathogen
antigen
viru
isol
antigen
variat
detect
amongst
isol
respons
neutral
polyclon
equin
antisera
monoclon
antibodi
mab
recogn
gl
protein
nucleotid
sequenc
comparison
eav
n
gl
gene
sequenc
confirm
genet
variat
exist
differ
viru
isol
comparison
deduc
amino
acid
sequenc
geograph
distinct
isol
shown
heterogen
n
protein
protein
gl
protein
one
variabl
region
gl
identifi
amino
acid
larg
percentag
substitut
found
outsid
one
variabl
region
found
gl
conserv
natur
suggest
minim
variat
toler
amino
acid
sequenc
structur
protein
differ
also
demonstr
pathogen
tissu
cultur
growth
characterist
glaser
unpublish
data
noth
yet
known
biolog
signific
demonstr
antigen
genom
sequenc
heterogen
evid
gl
n
protein
major
viral
antigen
humor
immun
respons
direct
first
convalesc
equin
sera
react
consist
gl
n
protein
almost
never
react
gs
protein
secondli
murin
mab
produc
immun
virion
shown
react
n
gl
gs
addit
ah
mab
neutral
activ
whose
specif
determin
react
gl
peptid
deriv
ectodomain
gl
protein
induc
neutral
antibodi
mice
rabbit
hors
consequ
gene
product
wide
studi
develop
antigen
use
diagnost
test
vaccin
see
figur
model
eav
virion
virion
rna
nucleocapsid
protein
n
form
isometr
nucleocapsid
enclos
lipid
envelop
contain
least
three
membran
protein
gl
protein
major
glycoprotein
virion
identifi
target
neutral
antibodi
serolog
clinic
evid
indic
eva
worldwid
distribut
seroreact
report
hors
donkey
mule
zebra
percentag
hors
seroposit
vari
among
countri
breed
gener
standardbr
high
thoroughbr
low
seropreval
known
differ
seropreval
reflect
differ
suscept
infect
mere
consequ
differ
risk
exposur
recent
serolog
survey
germani
indic
number
seroposit
hors
increas
around
increas
seropreval
also
report
sweden
itali
therefor
seem
within
certain
equin
popul
exposur
eav
increas
substanti
recent
past
recent
eav
isol
hors
howev
paweska
cowork
follow
detect
serum
antibodi
eav
donkey
demonstr
anim
suscept
infect
well
asinin
viru
transmit
vener
respiratori
rout
close
relat
nucleotid
sequenc
level
eav
isol
hors
addit
equin
isol
eav
use
experiment
infect
donkey
provid
evid
eav
host
rang
may
includ
equid
aerosol
exposur
eav
replic
initi
pulmonari
macrophag
rapidli
spread
throughout
bodi
infect
sever
cell
type
includ
endotheli
cell
compon
circulatori
system
smooth
muscl
cell
arteri
myometrium
lo
renal
tubular
epithelium
well
adren
epithelium
infrequ
liver
parenchyma
intestin
crypt
cell
bronchial
epithelium
experiment
infect
bucyru
isol
appear
fever
depress
edema
coincid
presenc
viral
antigen
within
endothelia
vein
lymphat
consequ
eav
infect
rang
subclin
cours
recogn
seroconvers
sever
ill
natur
outbreak
clinic
sign
variabl
gener
mild
sign
may
includ
pyrexia
depress
anorexia
edema
scrotum
ventral
trunk
limb
stiff
conjunct
lacrim
serou
nasal
discharg
urticaria
sever
clinic
sign
includ
respiratori
distress
weak
ataxia
colic
neonat
foal
present
acut
onset
respiratori
distress
result
rapidli
progress
bronchointerstiti
pneumonia
pneumoenter
syndrom
fatal
sever
sign
andor
mortal
rare
adult
except
experiment
infect
variant
bucyru
isol
clinic
sign
typic
begin
day
follow
aerosol
exposur
persist
day
case
vener
exposur
incub
period
day
viru
shed
nasopharyng
secret
urin
present
serum
bu
coat
viru
gener
isol
naaopharynx
buffjr
coat
day
post
infect
adult
mare
geld
gener
make
unev
recoveri
resist
clinic
diseas
afler
reexposur
perhap
lifetim
stallion
recov
clinic
becom
persist
infect
see
ratio
subclin
clinic
infect
report
outbreak
infect
spread
respiratori
rout
vari
vener
transmiss
ratio
vari
depend
stallion
involv
anoth
possibl
sequel
eav
infect
abort
may
occur
even
mare
clinic
sign
case
natur
exposur
abort
rate
vari
less
abort
rate
afler
experiment
infect
higher
abort
occur
mare
month
gestat
often
occur
late
acut
earli
convalesc
phase
infect
fetu
usual
expel
partial
autolys
may
expel
fresh
gross
lesion
common
lesion
present
includ
congest
edema
media
al
tissu
lymph
node
epicardi
hemorrhag
petechi
hemorrhag
pleural
periton
surfac
small
amount
clear
fluid
within
pleural
caviti
histopatholog
lesion
rare
report
except
one
incid
fetus
abort
result
eav
infect
widespread
necrot
vascul
mani
tissu
includ
liver
spleen
lung
brain
viru
readili
isol
placenta
tissu
bodi
fluid
fetu
may
serv
sourc
viru
infect
suscept
anim
pathogenesi
eav
induc
abort
yet
understood
unclear
respect
role
matern
versu
fetal
infect
sever
necrot
myometr
found
uteru
mare
experiment
infect
led
hypothesi
abort
due
decreas
fetal
support
caus
mechan
compress
blood
vessel
result
edema
decreas
uterin
progesteron
product
presenc
viral
antigen
demonstr
within
smooth
muscl
cell
myometrium
lo
provid
direct
evid
irrtlamm
seen
organ
due
part
presenc
replic
viru
recent
immunohistochem
identif
viral
antigen
within
areolar
trophoblast
togeth
evid
myometri
infect
suggest
abort
may
result
direct
impair
maternalfet
support
fetal
infect
hypothesi
tiuther
support
lack
lesion
fetu
inabl
demonstr
presenc
intracellular
viral
antigen
fetal
tissu
suggest
replic
viru
within
fetu
prior
abort
occur
therefor
play
major
role
pathogenesi
howev
one
report
widespread
vascul
two
fetus
abort
result
eav
infect
indic
may
strain
differ
abil
viru
caus
fetal
lesion
insuffici
evid
exist
rule
role
fetal
infect
abort
possibl
combin
pathogen
mechan
involv
matern
fetal
compon
involv
abort
compon
play
predomin
role
yet
determin
mare
geld
abl
elimin
viru
bodi
tissu
day
post
infect
stallion
becom
persist
infect
anim
viru
maintain
accessori
organ
reproduct
tract
princip
ampulla
va
deferen
shed
constantli
semen
three
carrier
state
exist
stallion
shortterm
state
convalesc
durat
sever
week
mediumterm
carrier
state
last
month
longterm
chronic
condit
may
persist
year
initi
infect
develop
mainten
viru
persist
larg
part
depend
presenc
testosteron
persist
infect
stallion
castrat
given
testosteron
continu
shed
viru
administ
placebo
ceas
viru
shed
addit
effort
establish
longterm
persist
prepubert
colt
appear
detect
concentr
circul
testosteron
induc
persist
eav
infect
castrat
male
hors
unsuccessml
howev
viru
could
still
isol
accessori
gland
reproduct
tract
prepuber
colt
day
post
infect
viru
could
detect
geld
day
suggest
even
absenc
detect
level
testosteron
accessori
sex
gland
colt
provid
permiss
atmospher
viral
persist
geld
presenc
testosteron
appear
essenti
establish
mainten
persist
genit
tract
infect
mechan
stallion
becom
persist
semen
shedder
unknown
viru
isol
reproduct
tract
shed
semen
stallion
acut
infect
abil
larg
percentag
stallion
effect
elimin
viru
time
suggest
differ
immun
respons
host
may
involv
yet
empir
evid
avail
support
suggest
altern
viru
strain
may
biolog
differ
influenc
abil
persist
reproduct
tract
establish
persist
may
involv
multifactori
process
depend
host
viral
factor
howev
sexual
rest
follow
acut
eav
infect
may
import
reduc
likelihood
stallion
becom
chronic
eav
carrier
clinic
recoveri
initi
infect
signific
decreas
fertil
shed
stallion
mare
infect
servic
carrier
stallion
appear
relat
fertil
problem
subsequ
year
report
mare
becom
eav
carrier
chronic
shedder
viru
passag
vener
rout
seroposit
mare
caus
clinic
diseas
seroconvers
stallion
foal
born
seroposit
mare
acquir
colostrum
matern
antibodi
eav
declin
extinct
within
month
previous
infect
hors
protect
clinic
diseas
infect
virul
viru
natur
immun
demonstr
persist
seven
year
may
persist
longer
presenc
neutral
antibodi
correl
well
protect
system
diseas
abort
develop
persist
infect
stallion
aerosol
vener
exposur
viru
two
major
rout
eav
spread
aerosol
gener
respiratori
secret
urin
acut
infect
anim
vener
infect
mare
viru
shed
stallion
figur
close
contact
anim
gener
requir
effici
viru
spread
aerosol
transmiss
personnel
viru
viabl
fresh
chill
frozen
semen
vener
transmiss
effici
seroneg
mare
seroconvert
bred
stallion
shed
viru
sever
case
outbreak
clinic
diseas
trace
persist
infect
stallion
mare
infect
vener
return
home
acut
eav
infect
spread
horizont
suscept
anim
area
mare
infect
late
gestat
may
pass
viru
vertic
fetu
foal
vertic
acquir
infect
born
weak
may
appear
normal
foal
usual
present
acut
onset
sever
respiratori
distress
within
day
birth
infect
lethal
diagnosi
clinic
eva
resembl
sever
viral
infect
equin
caus
equin
herp
viru
type
equin
rhinoviru
equin
intluenza
viru
equin
adenoviru
equin
infecti
anaemia
viru
definit
diagnosi
requir
laboratori
confnmat
acut
infect
diagnos
viru
isol
serolog
identifi
greater
rise
neutral
titer
acut
convalesc
serum
sampl
case
abort
viru
isol
attempt
fetal
placent
tissu
seroconvers
demonstr
mare
persist
infect
stallion
diagnos
first
screen
serum
antibodi
viru
neutral
vn
test
seroposit
titer
viru
isol
perform
untreat
spermrich
fraction
ejacul
stallion
test
mate
seroneg
mare
monitor
seroconvers
sever
method
use
detect
eavspecif
antibodi
serum
accord
oie
guidelin
detect
eavspecif
antibodi
current
baa
complementdepend
vn
test
vn
antibodi
titer
develop
week
follow
infect
maxim
month
remain
stabl
sever
year
endpoint
titer
determin
dilut
antibodi
result
protect
monolay
cytopath
effect
use
tissu
cultur
infect
dose
tciddso
unit
viru
standard
test
use
bucyru
isol
cell
titer
greater
duplic
sera
consid
eav
seroposit
comparison
sever
current
use
indic
virus
includ
sever
bucyru
isol
cross
neutral
experi
reveal
differ
exist
sensit
virus
neutral
convalesc
sera
hors
infect
experiment
heterolog
isol
high
initi
titer
homolog
viru
differ
signific
detect
lower
titer
indic
virus
might
problemat
subject
endpoint
use
differ
eav
strain
varieti
cell
line
differ
passag
histori
test
result
discrep
titer
valu
report
differ
laboratori
antibodi
eav
addit
demonstr
cf
test
enzymelink
immunosorb
assay
elisa
cf
test
potenti
use
detect
recent
infect
cf
titer
peak
week
infect
decreas
detect
limit
month
howev
diagnost
facil
offer
test
detect
eavspecif
antibodi
earliest
elba
test
develop
use
purifi
viru
sourc
antigen
major
problem
elisa
larg
number
falseposit
reaction
due
presenc
tissu
cultur
deriv
antigen
react
antibodi
present
larg
percentag
equin
sera
acquir
tissu
cultur
deriv
vaccin
follow
identif
gl
protein
promin
antigen
neutral
nonneutr
antibodi
produc
elba
base
bacteri
express
gl
ectodomain
eavutrecht
develop
elba
sensit
specif
detect
eavspecif
antibodi
hors
donkey
mule
sera
detect
presenc
specif
antibodi
posit
vn
respons
detect
absorb
valu
correl
well
neutral
antibodi
titer
elba
use
detect
differ
igg
igm
antibodi
level
donkey
may
util
distinguish
recent
histor
eav
infect
anoth
elisa
base
gl
protein
develop
use
multipl
ectodomain
sequenc
phylogenet
differ
isol
de
vri
et
al
unpublish
data
test
develop
recent
evid
consider
amino
acid
sequenc
variat
within
domain
viru
isol
sinc
part
gl
also
identifi
domin
neutral
sensit
site
cross
neutral
experi
suggest
hors
expos
differ
eav
isol
produc
antibodi
differenti
activ
might
part
attribut
variat
within
region
inclus
multipl
ectodomain
sequenc
could
theoret
improv
sensit
test
use
singl
ectodomain
sequenc
equin
sera
test
elba
singl
distinct
ectodomain
sequenc
clear
variat
effici
sequenc
recogn
elisa
base
n
protein
also
highli
sensit
specif
may
allow
differenti
antibodi
respons
promot
subunit
vaccin
due
infect
indic
elba
test
sensit
vn
test
current
use
potenti
disadvantag
test
posit
vn
test
directli
correl
biolog
protect
diseas
might
true
posit
elisa
test
nonneutr
well
neutral
antibodi
detect
current
test
identi
ing
viru
tissu
semen
viru
isol
cell
cultur
tissu
extract
dilut
semen
incub
togeth
permiss
cell
line
monolay
cultur
often
cell
cell
observ
cytopath
effect
viru
posit
identifi
immunofluoresc
immunocytochemistri
use
specif
polyclon
monoclon
antisera
test
vn
assay
defin
refer
antisera
isol
eav
cell
cultur
field
sampl
blood
semen
tissu
proven
problemat
instanc
cell
gener
sensit
abil
consist
isol
viru
depend
cell
subcultur
passag
level
pj
timoney
person
commun
proper
handl
sampl
collect
submiss
also
larg
impact
success
outcom
viru
isol
fail
provid
posit
answer
diagnosi
made
test
acut
convalesc
sera
vn
assay
determin
anim
seroconvert
altern
viru
transmiss
demonstr
inocul
blood
febril
hors
suscept
hors
follow
viru
isol
nasal
swab
blood
experiment
infect
hors
subsequ
seroconvers
eav
case
stallion
suspect
persist
infect
test
mate
seroneg
mare
test
mare
seroconvers
provid
definit
answer
addit
possibl
detect
presenc
viral
antigen
rna
without
need
tissu
cultur
exist
possibl
directli
identifi
viral
antigen
formalinfix
tissu
use
immunohistochemistri
may
use
establish
posit
diagnosi
formalinfix
materi
avail
presenc
viral
rna
detect
rtpcr
perform
tissu
semen
test
perform
two
set
nest
primer
sequenti
reaction
sensit
viru
isol
detect
viru
sinc
rtpcr
detect
rna
inform
would
avail
potenti
infecti
natur
viru
especi
relev
detect
viru
semen
limit
infecti
dose
determin
littl
known
infecti
statu
semen
viru
detect
rtpcr
viru
isol
case
respiratori
diseas
edta
heparin
titrat
blood
taken
soon
possibl
first
sign
ill
nasopharyng
conjunctiv
swab
also
submit
submers
suitabl
viral
transport
medium
sampl
chill
transport
quickli
compet
diagnost
laboratori
viru
isol
clot
blood
also
obtain
time
week
later
use
demonstr
seroconvers
event
foal
adult
anim
death
sampl
lung
liver
spleen
lymph
node
kidney
submit
viru
isol
rapid
transport
chill
sampl
possibl
store
ship
frozen
eav
relat
abort
fetu
placenta
contain
larg
amount
viru
sampl
placenta
spleen
lung
kidney
along
fetal
placent
fluid
collect
steril
manner
soon
possibl
abort
occur
chill
ice
submit
viru
isol
blood
obtain
mare
time
abort
three
week
later
test
vn
determin
stallion
seroposit
titer
vn
test
semen
sampl
collect
use
artifici
vagina
condom
phantom
teaser
mare
possibl
dismount
sampl
collect
time
breed
howev
less
satisfactori
sampl
spermrich
fraction
full
ejacul
chill
immedi
ship
arriv
diagnost
facil
within
hour
possibl
sampl
frozen
ship
diagnost
facil
condit
submiss
two
sampl
collect
day
consecut
day
recommend
wash
peni
antisept
disinfect
prior
collect
sampl
avoid
altern
stallion
test
mate
two
seroneg
mare
kept
isol
week
monitor
seroconvers
earli
studi
doll
et
al
demonstr
virul
eav
could
attenu
passag
tissu
cultur
retain
immunogen
serial
passag
hors
kidney
rabbit
kidney
equin
dermi
cell
serv
attenu
virul
viru
result
mod
live
vaccin
mlv
mlv
produc
side
effect
vaccin
hors
apart
short
term
abnorm
sperm
morpholog
mild
fever
overt
clinic
sign
howev
live
viru
isol
sporad
nasopharynx
blood
mlv
vaccin
vn
antibodi
titer
induc
within
day
persist
least
year
mlv
protect
clinic
diseas
reduc
amount
viru
shed
respiratori
tract
experiment
infect
hors
contact
mare
serv
vaccin
stallion
infect
eav
vaccin
mare
experiment
challeng
artifici
insemin
protect
clinic
diseas
infect
field
mlv
vaccin
arvac
fort
dodg
laboratori
use
control
eav
outbreak
state
usa
sinc
vaccin
licens
worldwid
fukunaga
cowork
pioneer
use
formalininactiv
whole
viru
vaccin
secondari
immun
week
primari
vaccin
result
vn
antibodi
titer
antibodi
titer
decreas
rapidli
third
immun
month
result
vn
titer
persist
month
protect
level
antibodi
calcul
vn
titer
howev
even
though
clinic
diseas
avert
hors
high
antibodi
level
protect
infect
sinc
live
viru
recov
blood
sampl
experiment
exposur
inactiv
vaccin
prevent
stallion
becom
semen
shedder
exposur
eav
protect
pregnant
mare
abort
outbreak
eva
inactiv
whole
viru
vaccin
artervac
fort
dodg
laboratori
avail
uk
ireland
vaccin
induc
high
neutral
antibodi
titer
produc
side
effect
efficaci
prevent
clinic
diseas
persist
infect
stallion
abort
reexposur
viru
still
unknown
test
vaccin
requir
gain
full
product
licens
uk
follow
identif
major
viral
epitop
eav
gl
protein
viral
subunit
use
immun
anim
attempt
induc
vn
respons
glspecif
peptid
amino
acid
residu
bacteri
express
msion
protein
residu
shown
induc
vn
antibodi
respons
vaccin
hors
second
glspecif
peptid
residu
induc
vn
antibodi
mice
protect
studi
subunit
vaccin
await
pivot
point
prevent
control
program
identif
persist
infect
stallion
institut
manag
procedur
prevent
introduct
eav
suscept
popul
breed
mare
natur
servic
artifici
insemin
best
way
prevent
eav
infect
spread
countri
breed
associ
propos
enforc
code
practic
follow
hors
owner
breeder
uk
horserac
bet
levi
board
distribut
annual
code
practic
novemb
aim
help
breeder
minim
risk
eva
hors
popul
make
recommend
diseas
prevent
control
breeder
respons
implement
code
breach
come
light
event
diseas
outbreak
anyon
intend
import
hors
semen
embryo
seek
inform
specialist
incid
eva
export
countri
individu
farm
semen
embryo
donor
must
test
import
import
anim
place
isol
immedi
arriv
kept
observ
day
time
blood
sampl
test
eav
antibodi
basic
first
step
prevent
diseas
individu
owner
serolog
screen
resid
anim
start
breed
season
normal
best
time
ii
request
anim
move
onto
premis
test
movement
stallion
prove
seroposit
use
breed
natur
servic
ai
shown
viru
free
shed
viru
stallion
might
still
use
certain
restrict
met
stallion
bred
mare
seroposit
either
natur
infect
vaccin
kept
isol
three
week
breed
seroposit
mare
repres
risk
stallion
hors
antibodi
statu
could
contirm
test
second
serum
sampl
week
first
import
establish
whether
infect
recent
histor
stabl
titer
would
indic
histor
infect
rise
titer
would
provid
evid
infect
recent
ie
within
last
sever
week
option
use
shed
stallion
breed
facil
may
depend
region
regul
within
eu
shed
stallion
present
stud
engag
intercommun
trade
semen
addit
semen
stallion
import
eu
must
certifi
seroneg
eav
seroposit
neg
viru
isol
result
semen
import
semen
stallion
shed
eav
also
prohibit
uk
eva
notifi
diseas
requir
ministri
agricultur
inform
seroposit
shed
stallion
mare
infect
vener
rout
ai
natur
mate
infect
anim
diseas
outbreak
outbreak
spread
eav
best
control
movement
restrict
isol
infect
anim
follow
quarantin
period
recoveri
good
hygien
includ
alloc
personnel
deal
sole
infect
anim
rigor
diagnost
surveil
infect
incontact
anim
option
use
vaccin
control
spread
diseas
also
avail
countri
follow
diseas
outbreak
subsequ
imposit
vaccin
polici
stringent
eav
control
program
gener
implement
may
includ
requir
annual
vaccin
noncarri
stallion
teaser
prior
breed
season
vaccin
seroneg
mare
serv
seroposit
carrier
stallion
countri
vaccin
polici
eva
anim
test
prior
first
vaccin
issu
certif
prove
origin
seroneg
statu
conclus
equin
viral
arter
entir
prevent
simpl
serosutveil
hygien
procedur
follow
hors
owner
breeder
keeper
establish
intern
code
practic
cover
aspect
diseas
includ
ai
embryo
transfer
enforc
equin
interest
group
state
veterinari
servic
would
certainli
help
limit
spreadof
diseas
code
clearli
speci
polici
diagnost
test
deal
persist
semen
shedder
could
includ
option
vaccin
control
dissemin
eav
requir
concert
effort
part
involv
equin
industri
current
intern
regul
creat
environ
longer
possibl
ignor
presenc
agent
semen
straightforward
epidemiolog
involv
fact
presenc
neutral
antibodi
correl
well
protect
diseas
abort
develop
persist
infect
stallion
evid
control
program
institut
like
successml
inde
success
